VNRX VolitionRx Limited

0.2260USD-6.96%Mkt Cap: 6.79M $P/E: —

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offer…

Key Statistics

Company
Market Cap6.79M USD
Enterprise Value10.56M USD
Revenue (TTM)2.46M USD
Gross Profit2.46M USD
Net Income (TTM)-23.36M USD
Revenue/Share0.36 USD
Last Price0.2260 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees57
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.29
PEG—
EV/EBITDA-0.57
EV/Revenue4.30
P/S2.97
P/B-0.09
EPS (TTM)-3.80
EPS (Forward)-0.85
52W Range
0.22040% of range14.80
52W High14.80 USD
52W Low0.2204 USD
Profitability
Gross Margin100.00%
Oper. Margin-1042.50%
EBITDA Margin0.00%
Profit Margin-1352.16%
ROE68.20%
ROA-338.45%
Growth
Revenue Growth-2.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.68M USD
CapEx (TTM)89.56K USD
FCF Margin-374.83%
FCF Yield-135.62%
Net Debt8.62M USD
Net Debt/EBITDA-0.46
Balance Sheet
Debt/Equity-0.33
Current Ratio0.30
Quick Ratio0.23
Book Value/Sh-2.67 USD
Cash/Share0.20 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateApr 28, 2026
Analyst Consensus
Rating—
Target (Mean)13.62 USD
Upside (mean)+5927.4%
Target Range2.000 USD – 24.00 USD
2.000+5927.4% to mean24.00
# Analysts5
Ownership
Shares Out.30.06M
Float12.06M
Insiders3.32%
Institutions10.80%
Short Interest
Short Ratio0.1d
Short % Float3.66%
Short % Out.3.60%
Shares Short1.00M
Short (prev mo.)683.89K
Technical
SMA 500.4610 (-51.0%)
SMA 2002.684 (-91.6%)
Beta1.17
S&P 52W Chg16.45%
Avg Vol (30d)3.20M
Avg Vol (10d)2.30M
Technical Indicators
RSI (14)24.8
MACD-0.0845
MACD Signal-0.1040
MACD Hist.+0.0195
BB Upper0.3398 USD
BB Middle0.2686 USD
BB Lower0.1975 USD
BB Width52.99%
ATR (14)0.0354 USD
Vol Ratio (20d)0.68x